Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Hematologic Diseases × Alemtuzumab × 90 days × Clear all

Sponsor

Conditions

Wilms Tumor 1 Sarcoma, Ewing 1 Rhabdomyosarcoma 1 Rhabdoid Tumor 1 Pseudomyxoma Peritonei 1 Neuroblastoma 1 Neoplasms, Germ Cell and Embryonal 1 Melanoma 1 Lymphoma 1 Digestive System Neoplasms 1 Carcinoma, Renal Cell 1 Carcinoma, Hepatocellular 1 Adenocarcinoma, Clear Cell 1

Interventions

pirtobrutinib 4 fludarabine phosphate 4 Mycophenolic Acid 4 Melphalan 4 Cyclophosphamide 4 fludarabine 3 Whole-Body Irradiation 3 Tacrolimus 3 Mesna 3 venetoclax 2 ibrutinib 2 Rituximab 2 Peripheral Blood Stem Cell Transplantation 2 Patient Reported Outcome Measures 2 Busulfan 2 Bone Marrow Transplantation 2 Azacitidine 2 ponatinib 1 pembrolizumab 1 cedazuridine 1 Vorinostat 1 Ustekinumab 1 Transplantation Conditioning 1 Quality of Life 1 Methotrexate 1 Lenalidomide 1 Interleukin-12 Subunit p40 1 Immunotherapy, Adoptive 1 Immunoglobulin G 1 Health Information Exchange 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡